Brenner Martin Insider Trading Activity

Average Profitability
<0.0001%
Insider Buys Quantity
1
Insider Buys Sum
$24,999.52
Insider Sells Quantity
11
Insider Sells Sum
$65,721.56

Insider Activity of Brenner Martin

According to the SEC Form 4 filings, Brenner Martin, being in a position of

  1. See Remarks at iBio, Inc.,
    оver the last 12 months, has bought 12336 shares for $24,919, and sold 0 shares,
    over all time since 2023-02-21, has bought 21527 shares for $49,918, and sold 92846 shares for $65,722.

Biography of Brenner Martin

No biography is available at this moment.

Statistics of Insider Transactions Last Year

Amount of Insider Buys and Sells by Stocks

Buys
 $24,9191100
Sells
 $000

Comparison of Insiders on Amount of Buys and Sells

2026-03-19PurchaseiBio, Inc.
IBIO
See Remarks
12,336
0.0752%
$2.02$24,919-30%
2025-01-10PurchaseiBio, Inc.
IBIO
See Remarks
9,191
0.1063%
$2.72$25,000-60%
2023-11-01SaleiBio, Inc.
IBIO
See Remarks
4,881
0.0175%
$0.27$1,296-63.98%
2023-10-03SaleiBio, Inc.
IBIO
See Remarks
5,267
0.0187%
$0.30$1,592-67.58%
2023-10-02SaleiBio, Inc.
IBIO
See Remarks
4,215
0.0154%
$0.31$1,311-68.63%
2023-08-28SaleiBio, Inc.
IBIO
See Remarks
5,011
0.0211%
$0.31$1,529-68.36%
2023-07-27SaleiBio, Inc.
IBIO
See Remarks
4,515
0.0337%
$0.51$2,308-78.92%
2023-07-12SaleiBio, Inc.
IBIO
See Remarks
47,020
0.3517%
$0.59$27,521-81.02%
2023-06-21SaleiBio, Inc.
IBIO
See Remarks
4,184
0.0322%
$0.68$2,849-81.57%
2023-05-22SaleiBio, Inc.
IBIO
See Remarks
4,182
0.032%
$0.94$3,910-71.51%
2023-04-24SaleiBio, Inc.
IBIO
See Remarks
4,382
0.0338%
$1.20$5,258-75.42%
2023-03-23SaleiBio, Inc.
IBIO
See Remarks
5,213
0.0411%
$2.13$11,112-84.88%
2023-02-21SaleiBio, Inc.
IBIO
See Remarks
3,976
0.0322%
$1.77$7,038-77.11%
Total: 13
Company
About Prismo.proIdeasArticlesPrivacy PolicyTerms of ServiceContact Us
Screener Ideas
Dividend StocksBlue Chip StocksDefensive StocksGrowth StocksValue StocksCyclical StocksPenny Stocks
Stock Tools
Insiders ScreenerStocks ScreenerTop StocksStock NewsInsider RatioList of All Stocks
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.